tiprankstipranks
Nymox Pharmaceutical (NYMXF)
OTHER OTC:NYMXF
US Market

Nymox Pharmaceutical (NYMXF) Financial Statements

Compare
141 Followers

Nymox Pharmaceutical Financial Overview

Nymox Pharmaceutical's market cap is currently $8.42M. The company's EPS TTM is $-0.095; its P/E ratio is ―; Nymox Pharmaceutical is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20Dec 19
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00-$ 116.00K
Gross Profit$ -11.00K$ -12.00K$ -12.00K-$ 49.00K
Operating Income$ -8.35M$ -6.65M$ -12.50M$ -11.72M$ -13.32M
EBITDA$ -8.77M$ -6.52M$ -12.49M$ -11.71M$ -13.12M
Net Income$ -8.84M$ -6.58M$ -12.54M$ -11.74M$ -13.16M
Balance Sheet
Cash & Short-Term Investments$ 70.00K$ 1.40M$ 830.00K$ 3.61M$ 5.24M
Total Assets$ 627.00K$ 1.63M$ 2.03M$ 4.93M$ 6.08M
Total Debt$ 750.00K$ 173.00K$ 391.00K$ 426.00K$ 147.00K
Net Debt$ 680.00K$ -1.23M$ -439.00K$ -3.19M$ -5.09M
Total Liabilities$ 3.80M$ 2.11M$ 1.95M$ 2.20M$ 2.04M
Stockholders' Equity$ -3.17M$ -482.00K$ 83.00K$ 2.73M$ 4.04M
Cash Flow
Free Cash Flow$ -4.06M$ -5.21M-$ -10.05M$ -7.43M
Operating Cash Flow$ -4.06M$ -5.21M$ -9.82M$ -10.04M$ -7.43M
Investing Cash Flow$ -3.00K$ 0.00-$ -13.00K$ 0.00
Financing Cash Flow$ 2.73M$ 5.78M$ 7.04M$ 8.42M$ 4.72M
Currency in USD

Nymox Pharmaceutical Earnings and Revenue History

Nymox Pharmaceutical Debt to Assets

Nymox Pharmaceutical Cash Flow

Nymox Pharmaceutical Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis